About Aaron Missere
Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.
Recent Articles By Aaron Missere
After Aurora Cannabis’ Announcement This Week, is the Stock a Buy?
Aurora Cannabis (ACB) recently announced it will need more money to finance operations and an analyst changed his tune on the stock. Does this provide a buying opportunity? Read more to get Aaron Missere's thoughts.
Should Investors Buy Cronos Group Ahead of Earnings Next Week?
The cannabis industry has seen its share of setbacks the past few months, and this earnings season has been the same. Will Cronos Group (CRON) be different? Read more to find out.
Should You Buy GW Pharmaceuticals Before They Report Earnings?
GW Pharmaceuticals (GWPH) has been trending lower since its last earnings report, but the stock's price doesn't reflect its revenue potential. Read more to learn if you should purchase the stock ahead of its upcoming earnings report.
Aphria: Should Cannabis Investors ‘Buy the Dip’?
Aphria (APHA) reported earnings last week and missed analyst expectations. This resulted in a strong drop in price, but Aaron thinks investors might not be seeing the whole picture. Read more to get his current thoughts on the company.
Could cbdMD Be the Next BIG Cannabis Stock?
While much of the cannabis industry is mired in a downturn, the CBD market looks like a bright spot. Here is one company focused on CBD that has been flying under the radar and worth a look: cbdMD (YCBD).
Can Aurora Cannabis’ Cost-Cutting Turn Things Around?
Aurora Cannabis (ACB) recently cut its stake in an Australian cannabis company. ACB is looking to cut costs in the hopes of turning things around. Will this strategy work? Aaron covers the move and how this will affect the company going forward.
Will Aurora Cannabis Ever Be Profitable?
For Aurora Cannabis (ACB), the bad news keeps coming. After a bad quarter and lowered forecasts, investors wonder if the company will ever be profitable. Read more to learn Aaron's take on the company's current situation and future prospects.
Is Aphria's Stock a Long-Term Buy?
The cannabis market has suffered due to the pandemic, but one company stands above the rest, Aphria (APHA). APHA has been growing its revenue and its products are well-liked. Learn why you should consider adding this stock to your portfolio.
Innovative Industrial Properties Makes Another Splash with New Acquisition
Innovative Industrial Properties (IIPR) announced a new acquisition last week from an affiliate of Parallel, the corporate parent to Surterra Wellness. Learn how this might affect the company's outlook and growth potential.